Veterinary News,
Explained.

FDA approved AQUI-S E10% (eugenol immersion solution) to sedate freshwater finfish to a handleable condition during field-use activities such as spawning, tagging, weighing, and measuring. FDA states that treated fish typically recover within 15 minutes or less depending on dose and species and may be released after recovery.

FDA approved Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs, calling it the first approved treatment for both conditions in dogs.

FDA approved Amodip (amlodipine besylate chewable tablets) for control of systemic hypertension in cats, describing it as the first FDA-approved amlodipine product for veterinary use.

FDA approved a generic moxidectin oral drench for treatment and control of internal parasites in sheep, including information on dosing and withdrawal restrictions.

FDA announced approval of the first generic omeprazole oral paste for treatment of gastric ulcers in horses, adding a lower-cost option in an area many owners and equine practices already know well.

FDA approved the first generic injectable robenacoxib for postoperative pain and inflammation associated with certain surgeries in dogs and cats.

FDA granted full approval to KBroVet for control of seizures associated with idiopathic epilepsy in dogs.

FDA granted full approval to Laverdia, described as the first oral treatment for lymphoma in dogs.

FDA approved the first generic robenacoxib tablets for postoperative pain and inflammation in cats following certain common surgeries.

FDA supplemented approval of Vetmedin to include delaying onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease.

FDA approved the first generic methimazole coated tablets for treating feline hyperthyroidism, expanding access to a common medical therapy for an older-cat endocrine disease.

FDA approved Bravecto Quantum, an extended-release injectable suspension that protects dogs against fleas and ticks for 8 to 12 months, the first FDA-approved long-acting treatment of its kind.

FDA approved the first generic cefovecin sodium injection for treating certain skin infections, abscesses, and wounds in dogs and cats, creating a generic version of Convenia for prescription veterinary use.